Artiva Biotherapeutics (ARTV) Current Leases (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Current Leases of $3.0 million for Q1 2026, down 15.86% year-over-year from $3.6 million in Q1 2025, and little changed quarter-over-quarter from $3.0 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Current Leases (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Current Leases for 4 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 15.86% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 15.86% YoY), while the FY2025 annual figure was $3.0 million, up 2371.31% from the prior year.
- Current Leases held at $3.0 million in Q1 2026 per ARTV's latest filing, from $3.0 million in the prior quarter.
- Across five years, Current Leases topped out at $3.7 million in Q2 2024 and bottomed at $75000.0 in Q3 2025.
- Historically, Current Leases has averaged $2.3 million across 4 years, with a median of $3.0 million in 2026.
- On a YoY basis, Current Leases climbed as much as 2371.31% in 2025 and fell as far as 97.92% in 2025.
- Artiva Biotherapeutics' Current Leases stood at $3.6 million in 2023, then tumbled by 96.61% to $122000.0 in 2024, then soared by 2371.31% to $3.0 million in 2025, then grew by 0.3% to $3.0 million in 2026.
- Business Quant data shows ARTV's Current Leases at $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $75000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 3.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.30 Mn |
| Mar 31, 2026 | 3.02 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 106,000.00 |
| Mar 31, 2025 | 3.59 Mn |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 3.67 Mn |
| Dec 31, 2023 | 3.60 Mn |